Genetic Testing for APOL1 Genetic Variants in Clinical Practice: Finally Starting to Arrive

Clin J Am Soc Nephrol. 2020 Jan 7;15(1):126-128. doi: 10.2215/CJN.01810219. Epub 2019 Nov 18.
No abstract available

Keywords: end stage kidney disease; genetic testing; genetic variants; genetic variation; kidney disease.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Apolipoprotein L1 / genetics*
  • Black People / genetics
  • Clinical Decision-Making
  • Genetic Predisposition to Disease
  • Genetic Testing*
  • Genetic Variation*
  • Glomerular Filtration Rate
  • Humans
  • Kidney / physiopathology
  • Kidney Diseases / diagnosis
  • Kidney Diseases / ethnology
  • Kidney Diseases / genetics*
  • Kidney Diseases / physiopathology
  • Phenotype
  • Predictive Value of Tests
  • Prognosis
  • Risk Assessment
  • Risk Factors

Substances

  • APOL1 protein, human
  • Apolipoprotein L1